411 related articles for article (PubMed ID: 33080952)
1. The Wnt Signalling Pathway: A Tailored Target in Cancer.
Koni M; Pinnarò V; Brizzi MF
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080952
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.
Yang G; Shen T; Yi X; Zhang Z; Tang C; Wang L; Zhou Y; Zhou W
J Cell Mol Med; 2018 Apr; 22(4):2062-2070. PubMed ID: 29392884
[TBL] [Abstract][Full Text] [Related]
3. [WNT-β-catenin signaling pathway and its relationship with cancer].
Ochoa-Hernández AB; Juárez-Vázquez CI; Rosales-Reynoso MA; Barros-Núñez P
Cir Cir; 2012; 80(4):389-98. PubMed ID: 23374390
[TBL] [Abstract][Full Text] [Related]
4. The Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy.
A Najafi SMA
Iran Biomed J; 2020 Sep; 24(5):269-80. PubMed ID: 32429632
[TBL] [Abstract][Full Text] [Related]
5. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
7. The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer.
Peng Y; Zhang X; Feng X; Fan X; Jin Z
Oncotarget; 2017 Feb; 8(8):14089-14106. PubMed ID: 27793042
[TBL] [Abstract][Full Text] [Related]
8. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
Rahmani F; Avan A; Hashemy SI; Hassanian SM
J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
Dzobo K; Thomford NE; Senthebane DA
OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
[TBL] [Abstract][Full Text] [Related]
10. The Wnt pathway: emerging anticancer strategies.
Gupta A; Verma A; Mishra AK; Wadhwa G; Sharma SK; Jain CK
Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):138-47. PubMed ID: 23432158
[TBL] [Abstract][Full Text] [Related]
11. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
12. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer.
Ghahhari NM; Babashah S
Eur J Cancer; 2015 Aug; 51(12):1638-49. PubMed ID: 26025765
[TBL] [Abstract][Full Text] [Related]
13. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles containing oncogenic mutant β-catenin activate Wnt signalling pathway in the recipient cells.
Kalra H; Gangoda L; Fonseka P; Chitti SV; Liem M; Keerthikumar S; Samuel M; Boukouris S; Al Saffar H; Collins C; Adda CG; Ang CS; Mathivanan S
J Extracell Vesicles; 2019; 8(1):1690217. PubMed ID: 31819794
[TBL] [Abstract][Full Text] [Related]
15. Wnt-β-catenin signalling in liver development, health and disease.
Perugorria MJ; Olaizola P; Labiano I; Esparza-Baquer A; Marzioni M; Marin JJG; Bujanda L; Banales JM
Nat Rev Gastroenterol Hepatol; 2019 Feb; 16(2):121-136. PubMed ID: 30451972
[TBL] [Abstract][Full Text] [Related]
16. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
Wang J; Shibayama Y; Zhang A; Ohsaki H; Asano E; Suzuki Y; Kushida Y; Kobara H; Masaki T; Wang Z; Nishiyama A
Br J Cancer; 2019 Jan; 120(2):229-237. PubMed ID: 30555158
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: The key players regulating the crosstalk between Hippo and Wnt/β-catenin pathways in breast cancer.
Doloi R; Gupta SM
Life Sci; 2023 Sep; 329():121980. PubMed ID: 37516428
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
Nguyen VHL; Hough R; Bernaudo S; Peng C
J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
[TBL] [Abstract][Full Text] [Related]
19. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
